CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,976,580
- in 4 filings, $5.0M under 10b5-1 plans
Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-24 | Cox John Director | Sale | −1,858 | $96.72 | $180K | 923 |
| 2020-03-18 | Cox John Director | Exercise or conversion | +14,000 | $12.91 | $181K | 16,781 |
| 2020-03-18 | Cox John Director | Exercise or conversion | +3,632 | $41.19 | $150K | 20,413 |
| 2020-03-18 | Cox John Director | Exercise or conversion | +3,366 | $26.12 | $88K | 23,779 |
| 2020-03-18 | Cox John Director | Exercise or conversion | +2,434 | $38.76 | $94K | 26,213 |
| 2020-03-18 | Cox John Director | Exercise or conversion | +3,304 | $42.07 | $139K | 29,517 |
| 2020-03-18 | Cox John Director | Sale | −24,533 | $95.13 | $2.3M | 4,984 |
| 2020-03-18 | Cox John Director | Sale | −1,187 | $96.45 | $114K | 3,797 |
| 2020-03-18 | Cox John Director | Sale | −1,016 | $97.17 | $99K | 2,781 |
| 2020-03-18 | Cox John Director | Exercise or conversion · Stock Option (Right to Buy) | −14,000 | 0 | ||
| 2020-03-18 | Cox John Director | Exercise or conversion · Stock Option (Right to Buy) | −3,632 | 0 | ||
| 2020-03-18 | Cox John Director | Exercise or conversion · Stock Option (Right to Buy) | −3,366 | 0 | ||
| 2020-03-18 | Cox John Director | Exercise or conversion · Stock Option (Right to Buy) | −2,434 | 0 | ||
| 2020-03-18 | Cox John Director | Exercise or conversion · Stock Option (Right to Buy) | −3,304 | 0 | ||
| 2020-03-04 | Cox John Director | Exercise or conversion | +10,000 | $12.91 | $129K | 12,781 |
| 2020-03-04 | Cox John Director | Sale | −10,000 | $93.39 | $934K | 2,781 |
| 2020-03-04 | Cox John Director | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 14,000 | ||
| 2020-02-24 | Cox John Director | Sale | −100 | $94.85 | $9K | 7,136 |
| 2020-02-24 | Cox John Director | Sale | −4,355 | $92.76 | $404K | 2,781 |
| 2019-05-15 | Cox John Director | Grant or award | +923 | 7,236 |
Page 1 of 2 · 21 trades